Marrow
Genomics · Genetic Reports · Precision Wellness

Male Sexual Health

Personalized Genetic Report
Sexual HealthSexually Transmitted InfectionsSex HormonesProstate Health
Sample ClientReport date: 29 July 2026
Genomics · Genetic Reports · Precision Wellness
Marrow Health Laboratories
Marrow
Accession #: MRW-26-158F77
Report type: Full Report
Report status: FINAL

Specimen and client information

Client
Sample Client
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Accession
MRW-26-158F77
Panel
Male Sexual Health
Results scored
17
Need attention
4
Report
Full Report

What this report covers

Sexual Health · Sexually Transmitted Infections · Sex Hormones · Prostate Health

About this report

This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.

What each result group means

Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.

Your results at a glance

How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 17 results here, 4 came back worth discussing with a clinician and 1 came back in your favour. Bring this document to your appointment.
Worth a conversation with your doctor  (4)These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
From your Male Sexual Health report
AGenital Herpes
More likely
Higher predisposition than 98% of people
HASPIN rs7503464 AG · ANKRD30A rs148685730 TC · SH2D4B rs539848481 GC · TAMM41 rs144232229 GG · ADAM32 rs117705146 GG · ATP1B3 rs538162817 TT · CDH23 rs190960403 CC · POLR3A rs144589616 GG
AProstate Cancer
More likely
Higher predisposition than 94% of people
FSTL5 rs7691481 CC · FGF9 rs781386326 GG · GINS4 rs56336841 CC · KCND2 rs73429913 CC · TNFSF11 rs532873142 CC
AProstate Inflammation
More likely
Higher predisposition than 94% of people
GATA5 rs200383755 GG · GATA3 rs17144046 AG · NCL rs62199052 GC · MACROH2A1 rs677394 CC · H4C13 rs200476 AA · GCLC rs534957 CG · STARD4 rs10054105 TT · GATA6 rs9958656 TT
ASexual Dysfunction
More likely
Higher predisposition than 90% of people
CHSY3 rs13436218 TT · MDGA2 rs1160351 CC · ABCC4 rs117651201 AA · EBF2 rs113716552 CC · S1PR1 rs76296920 AA · NNMT rs145841294 GG · FNDC3A rs78447716 AA
Running above the typical range  (2)Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
From your Male Sexual Health report
HEstradiol (M)
Higher levels
Above the typical range
ESR1 rs728524 AA · ESR1 rs9340799 GA · ESR1 rs2234693 CT · XDH rs559555 TT · GCKR rs1260326 TC · EDA2R rs12850857 G · SRD5A2 rs112881196 CC · FKBP4 rs56196860 CC
HTestosterone
Higher levels
Above the typical range
FKBP4 rs56196860 CC · EDA2R rs141086308 C · TNFSF12 rs727428 TT · PDE7B rs7774640 GG · FAM9A rs5934505 T · TNFSF12 rs12946520 TG · NR2F2 rs8023580 TT · MYPOP rs35318830 TT
Running below the typical range  (0)Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Nothing in this group.
Working in your favour  (1)Good news. Your genetics look protective or better than average here.
From your Male Sexual Health report
FTesticular Cancer
Less likely
Lower predisposition than average
KITLG rs995030 GG · MANBA rs7659556 TT · ATF7IP rs2900333 CC · CLPTM1L rs36115365 CG · RFTN1 rs10510452 GA · MANBA rs2720460 AG · MPO rs9905704 TG · UCK2 rs3790672 CT
In line with most people  (10)Nothing unusual. These were tested and came back typical — worth having on record.
From your Male Sexual Health report
·Enlarged Prostate
Typical likelihood
In line with the general population · 77th percentile
GATA5 rs200383755 GG · GATA3 rs17144046 AG · MACROH2A1 rs677394 CC · H4C13 rs200476 AA · GCLC rs534957 CG · STARD4 rs10054105 TT · GATA6 rs9958656 TT · TBX5 rs2555019 CC
·Painful Intercourse
Typical likelihood
In line with the general population · 74th percentile
·Erectile Dysfunction
Typical likelihood
In line with the general population · 71th percentile
POU5F1B rs201885483 GG · ALCAM rs9810233 AG · PDK1 rs836589 GA · PHACTR2 rs6931865 AG · SIM1 rs17185536 CC · SIM1 rs57989773 TT · ANTXR2 rs71612990 TT · ABCC4 rs117651201 AA
·Penile Curvature
Typical likelihood
In line with the general population · 68th percentile
·Chlamydia
Typical likelihood
In line with the general population · 62th percentile
NPSR1 rs720756 TT · MT1X rs79741827 TT · MANBA rs6821248 GG · PIGN rs61755362 GG · SIGLEC1 rs150358287 CC · STARD3 rs11556624 GG · OR13F1 rs79177442 GG · SLC1A7 rs116623976 GG
·HPV Infection
Typical likelihood
In line with the general population · 46th percentile
DOK5 rs1293153 GG · RHOBTB1 rs145804860 CT · ABHD2 rs405103 CC · GPR26 rs78231715 CC · MPZL2 rs145674624 GG · TCERG1L rs186242350 CC · FDX1 rs74572764 TT · KAT6B rs192376670 CC
·HIV/AIDS
Typical likelihood
In line with the general population
NTNG1 rs4118325 GG · PABPC1 rs3108919 TT · NFIB rs1556032 TT
·Bioavailable Testosterone
Typical levels
In line with the general population
SRD5A2 rs113017476 GG · PPP2R3C rs10137488 TT · KCNIP4 rs7679843 CC · MME rs61762319 AA · ORM1 rs10982156 TT · CYP19A1 rs17703883 TT · ABT1 rs79310511 AA · RORB rs912202 GG
·DHT
Typical levels
In line with the general population
TNFSF12 rs1799941 GG
·Progesterone
Typical levels
In line with the general population
HSD17B12 rs142754737 CC · SESN3 rs139203625 CC · CD34 rs138621610 GG · ARNTL rs77032081 CC · RBFOX1 rs144711998 CC · LYSMD3 rs139441768 TT · ARRDC3 rs140935700 GG · ZKSCAN5 rs34670419 GG

Methodology

Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.

Limitations

This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.

Performing laboratory & attestation
Performing laboratoryGene by Gene, Ltd.
Laboratory address1445 North Loop West, Suite 760, Houston, TX 77008
CLIA certificationCLIA #45D1102202
CAP accreditationCAP #7212851 · accredited through 7 October 2027
Laboratory DirectorFeng Zhou, PhD, MB(ASCP)
Specimen typeBuccal (cheek) swab — genomic DNA
AccessionMRW-26-158F77
Date reported29 July 2026

This specimen was tested at Gene by Gene, Ltd., 1445 North Loop West, Suite 760, Houston, TX 77008, under CLIA #45D1102202 and CAP #7212851. Laboratory Director: Feng Zhou, PhD, MB(ASCP). Marrow Health is not a clinical laboratory and does not perform testing; Marrow prepares and delivers this report from data produced by the performing laboratory named above. Report generated 29 July 2026 · Accession MRW-26-158F77 · © 2026 Marrow Health.